The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study
Open accessAbstract
Background Accurate diagnosis and early detection of complex diseases, such as Parkinson's disease, has the potential to be of great benefit for researchers and clinical practice. We aimed to create a non-invasive, accurate classification model for the diagnosis of Parkinson's disease, which could serve as a basis for future disease prediction studies in longitudinal cohorts.Methods We developed a model for disease classification using data from the Parkinson's Progression Marker Initiative (PPMI) study for 367 patients with Parkinson's disease and phenotypically typical imaging data and 165 controls without neurological disease. Olfactory function, genetic risk, family history of Parkinson's disease, age, and gender were algorithmically selected by stepwise logistic regression as significant contributors to our classifying model. We then tested the model with data from 825 patients with Parkinson's disease and 261 controls from five independent cohorts with varying recruitment strategies and designs: the Parkinson's Disease Biomarkers Program (PDBP), the Parkinson's Associated Risk Study (PARS), 23andMe, the Longitudinal and Biomarker Study in PD (LABS-PD), and the Morris K Udall Parkinson's Disease Research Center of Excellence cohort (Penn-Udall). Additionally, we used our model to investigate patients who had imaging scans without evidence of dopaminergic deficit (SWEDD).Findings In the population from PPMI, our initial model correctly distinguished patients with Parkinson's disease from controls at an area under the curve (AUC) of 0·923 (95% CI 0·900-0·946) with high sensitivity (0·834, 95% CI 0·711-0·883) and specificity (0·903, 95% CI 0·824-0·946) at its optimum AUC threshold (0·655). All Hosmer-Lemeshow simulations suggested that when parsed into random subgroups, the subgroup data matched that of the overall cohort. External validation showed good classification of Parkinson's disease, with AUCs of 0·894 (95% CI 0·867-0·921) in the PDBP cohort, 0·998 (0·992-1·000) in PARS, 0·955 (no 95% CI available) in 23andMe, 0·929 (0·896-0·962) in LABS-PD, and 0·939 (0·891-0·986) in the Penn-Udall cohort. Four of 17 SWEDD participants who our model classified as having Parkinson's disease converted to Parkinson's disease within 1 year, whereas only one of 38 SWEDD participants who were not classified as having Parkinson's disease underwent conversion (test of proportions, p=0·003).Interpretation Our model provides a potential new approach to distinguish participants with Parkinson's disease from controls. If the model can also identify individuals with prodromal or preclinical Parkinson's disease in prospective cohorts, it could facilitate identification of biomarkers and interventions.Funding National Institute on Aging, National Institute of Neurological Disorders and Stroke, and the Michael J Fox Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Parkinson’s disease (PD) is a debilitating neurodegenerative disorder characterized by the accumulation of alpha-synuclein (αSyn) within neurons and the loss of neuronal cells1.”
From Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model (2024) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“We found four significant genetic correlations (FDR-adjusted P < 0.05, Table S10) including positive correlations with intracranial volume and putamen volume (42), and negative correlations with current tobacco use and “academic qualifications: National Vocational Qualifications (NVQ) or Higher National Diploma (HND) or Higher National Certificate (HNC) or equivalent” (43).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [43]
In the citing paper
“We found four significant genetic correlations (FDR-adjusted P < 0.05, Table S10) including positive correlations with intracranial volume and putamen volume (42), and negative correlations with current tobacco use and “academic qualifications: National Vocational Qualifications (NVQ) or Higher National Diploma (HND) or Higher National Certificate (HNC) or equivalent” (43).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [43]
In the citing paper
“We found four significant genetic correlations (FDR-adjusted P < 0.05, Table S10) including positive correlations with intracranial volume and putamen volume (42), and negative correlations with current tobacco use and “academic qualifications: National Vocational Qualifications (NVQ) or Higher National Diploma (HND) or Higher National Certificate (HNC) or equivalent” (43).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,088
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán‐Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munaín, A. L., Aparicio, S. F., Gil, A. M., Khan, N. L., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,448
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Self-citationA REVIEW OF GOODNESS OF FIT STATISTICS FOR USE IN THE DEVELOPMENT OF LOGISTIC REGRESSION MODELS1
LEMESHOW, S., & HOSMER, D. W. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113284 · Cited by 1,947
International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), et al. (2014) · Nature Genetics · doi:10.1038/ng.3043 · Cited by 1,895
Self-citationWang, E., Yao, H.-B., Chen, Y., Wang, G., Gao, W., Sun, Y., Guo, J., Hu, J., Jiang, C., & Hu, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350082 · Cited by 1,185
Nalls, M. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62345-8 · Cited by 922
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
Postuma, R. B., Aarsland, D., Barone, P., Burn, D. J., Hawkes, C. H., Oertel, W. H., & Ziemssen, T. (2012) · Movement Disorders · doi:10.1002/mds.24996 · Cited by 615
Lill, C. M., Roehr, J. T., McQueen, M. B., Kavvoura, F. K., Bagade, S., Schjeide, B. M., Schjeide, L. M., Meissner, E., Zauft, U., Allen, N. C., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002548 · Cited by 541
Cited by
Sorted by citations
Items 101–200 of 204
Oulas, A., Minadakis, G., Zachariou, M., & Spyrou, G. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-39796-w · Cited by 22
Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
MAREK, K. L., Russell, D., Concha‐Marambio, L., Choi, S. H., Jennings, D. L., Brumm, M. C., Coffey, C. S., Brown, E. G., Seibyl, J. P., Stern, M., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105567 · Cited by 22
Pharmacogenetics of Parkinson's Disease in Clinical Practice
Corvol, J., & Poewe, W. H. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12444 · Cited by 21
Nonmotor symptoms and Parkinson disease in United States farmers and spouses
Shrestha, S., Kamel, F., Umbach, D. M., Freeman, L. E. B., Koutros, S., Alavanja, M. C. R., Sandler, D. P., & Chen, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185510 · Cited by 20
Parkinson’s disease prognostic scores for progression of cognitive decline
Gramotnev, G., Gramotnev, D. K., & Gramotnev, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-54029-w · Cited by 19
Genetic Stratification of Age‐Dependent Parkinson's Disease Risk by Polygenic Hazard Score
Pihlstrøm, L., Fan, C. C., Frei, O., Tan, M. M. X., Karunamuni, R. A., Blauwendraat, C., Bandrés‐Ciga, S., Gan‐Or, Z., Grosset, D. G., Dale, A. M., et al. (2021) · Movement Disorders · doi:10.1002/mds.28808 · Cited by 19
Vuletić, V., Rački, V., Papić, E., & Peterlin, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137213 · Cited by 21
Brolin, K. A., Bandrés‐Ciga, S., Blauwendraat, C., Widner, H., Odin, P., Hansson, O., Puschmann, A., & Swanberg, M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212818 · Cited by 15
Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors
Liu, H., Dehestani, M., Blauwendraat, C., Makarious, M. B., Leonard, H. L., Kim, J. J., Schulte, C., Noyce, A. J., Jacobs, B. M., Foote, I. F., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26416 · Cited by 18
Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease
Fischer, D. L., Auinger, P., Goudreau, J. L., Paumier, K. L., Cole-Strauss, A., Kemp, C. J., Lipton, J. W., & Sortwell, C. E. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.05.003 · Cited by 19
Genome Sequencing in the Parkinson Disease Clinic
Hill, E. J., Robak, L. A., Al‐Ouran, R., Deger, J., Fong, J. C., Vandeventer, P. J., Schulman, E., Rao, S., Saade, H., Savitt, J. M., et al. (2022) · Neurology Genetics · doi:10.1212/nxg.0000000000200002 · Cited by 18
Using machine learning to identify Parkinson’s disease severity subtypes with multimodal data
Park, H., Youm, C., Cheon, S., Kim, B., Choi, H., Hwang, J., & Kim, M. (2025) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-025-01648-2 · Cited by 19
Terroba‐Chambi, C., Rossi, M., Bril, A., Vernetti, P. M., Cerquetti, D., Cammarota, Á., & Merello, M. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12517 · Cited by 18
Açıkgöz, H., Korkmaz, D., & Talan, T. (2024) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-024-01316-2 · Cited by 16
Olsson, T. T., Svensson, M., Hållmarker, U., James, S. K., & Deierborg, T. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191762 · Cited by 16
Schaeffer, E., Yılmaz, R., Louis, E. K. S., & Noyce, A. J. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230428 · Cited by 15
Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease
Auger, S. D., Kanavou, S., Lawton, M., Ben‐Shlomo, Y., Hu, M. T., Schrag, A. E., Morris, H. R., Grosset, D. G., & Noyce, A. J. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12928 · Cited by 15
Predicting Parkinson disease in the community using a nonmotor risk score
Darweesh, S. K. L., Koudstaal, P. J., Stricker, B. H. C., Albert Hofman, D., Steyerberg, E. W., & Ikram, M. A. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-016-0130-1 · Cited by 15
Novel biomolecular information in rotenone-induced cellular model of Parkinson's disease
Lin, D., Liang, Y., Zheng, D., Chen, Y., Jing, X., Lei, M., Zeng, Z., Zhou, T., Wu, X., Peng, S., et al. (2018) · Gene · doi:10.1016/j.gene.2018.01.023 · Cited by 16
Gottesman, J., Karim, Y., Forbes, J., Kirsch, L., Stagman, K., Korell, M., & Tanner, C. M. (2024) · Scientific Data · doi:10.1038/s41597-024-03407-9 · Cited by 15
Applications of artificial intelligence‐driven microfluidics in medical laboratory science
Jiang, Q., Mo, Q., Ge, C., Li, W., Mai, J., Chen, Y., Liu, Y., Deng, X., Yang, Z., & Wang, D. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20240135 · Cited by 14
Moving towards the detection of frailty with biomarkers: A population health study
Sargent, L. J., Nalls, M. A., Singleton, A., Palta, P., Kucharska‐Newton, A., Pankow, J. S., Young, H. J., Tang, W., Lutsey, P. L., Olex, A., et al. (2023) · Aging Cell · doi:10.1111/acel.14030 · Cited by 14
Cognitive and Functional Trajectories in Older Adults With Prediagnostic Parkinson Disease
Bock, M., Vittinghoff, E., Bahorik, A. L., Leng, Y., Fink, H. A., & Yaffe, K. S. (2022) · Neurology · doi:10.1212/wnl.0000000000206762 · Cited by 13
Genetic risk of Parkinson’s disease in the general population
Darweesh, S. K. L., Verlinden, V. J. A., Adams, H. H. H., Uitterlinden, A. G., Hofman, A., Stricker, B. H., van Duijn, C. M., Koudstaal, P. J., & Ikram, M. A. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.030 · Cited by 13
Combining clinical and biofluid markers for early Parkinson's disease detection
Yu, Z., Stewart, T., Aasly, J. O., Shi, M. Y., & Zhang, J. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.509 · Cited by 13
Burciu, R. G., Seidler, R. D., Shukla, P., Nalls, M. A., Singleton, A., Okun, M. S., & Vaillancourt, D. E. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.001 · Cited by 13
Bi, X.-A., Wu, H., Xie, Y., Zhang, L., Luo, X., Fu, Y., & Initiative, A. D. N. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00392-6 · Cited by 13
Bestwick, J. P., Auger, S. D., Schrag, A. E., Grosset, D. G., Kanavou, S., Giovannoni, G., Lees, A. J., Cuzick, J. M., & Noyce, A. J. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00226-2 · Cited by 13
Meng, J., Wang, F., Ji, L., Liang, Y., Wei, N., Song, L., & Zhu, A. (2021) · Epigenomics · doi:10.2217/epi-2021-0176 · Cited by 12
Tremblay, C., Adler, C. H., Shill, H. A., Driver‐Dunckley, E. D., Mehta, S. H., Choudhury, P., Belden, C. M., Shprecher, D., Lee‐Iannotti, J. K., Atri, A., et al. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14244 · Cited by 12
Hassanin, E., Landoulsi, Z., Pachchek, S., Acharya, G., Aguayo, G., Alexandre, M., Ali, M., Ammerlann, W., Arena, G., Bassis, M., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00997-y · Cited by 12
Excess of singleton loss-of-function variants in Parkinson’s disease contributes to genetic risk
Bobbili, D. R., Banda, P., Krüger, R., & May, P. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106316 · Cited by 12
Leger, C. S., Herbert, M., & DeSouza, J. F. X. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00364 · Cited by 12
Multi-Modality Machine Learning Predicting Parkinson’s DiseasePreprint
Makarious, M. B., Leonard, H. L., Vitale, D., Iwaki, H., Sargent, L. J., Dadu, A., Violich, I., Hutchins, E. D., Saffo, D., Bandrés‐Ciga, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.05.434104 · Cited by 12
Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
Dou, K., Ma, J., Zhang, X., Shi, W., Tao, M., & Xie, A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.977985 · Cited by 11
A Comprehensive Review of the Role of Biomarkers in Early Diagnosis of Parkinson’s Disease
Das, S., & Ramteke, H. B. (2024) · Cureus · doi:10.7759/cureus.54337 · Cited by 11
Effect of polygenic load on striatal dopaminergic deterioration in Parkinson disease
Lee, M. J., Pak, K., Kim, J., Kim, Y. J., Yoon, J., Lee, J., Lyoo, C. H., Park, H. J., Lee, J., & Jung, N. (2019) · Neurology · doi:10.1212/wnl.0000000000007939 · Cited by 11
Non-Motor Features of Parkinson’s Disease in Women
Hughes, K. C., Gao, X., Baker, J. M., Stephen, C. D., Kim, I. Y., Valeri, L., Schwarzschild, M. A., & Ascherio, A. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202409 · Cited by 11
COMPARISON OF STATIC POSTURAL BALANCE IN PATIENTS WITH SWEDDS AND PARKINSON’S DISEASE
Kwon, D., Choi, Y.-H., KWON, Y.-R., Eom, G., & Kim, J. (2020) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519420400138 · Cited by 10
Polygenic load: Earlier disease onset but similar longitudinal progression in Parkinson's disease
Lerche, S., Liepelt‐Scarfone, I., Wurster, I., Schulte, C., Schäffer, E., Röeben, B., Machetanz, G., Zimmermann, M., Akbas, S., Hauser, A., et al. (2018) · Movement Disorders · doi:10.1002/mds.27427 · Cited by 10
Blauwendraat, C., Noyce, A. J., Mata, I. F., Screven, L. A., Solle, J. C., Dumanis, S. B., Riley, E. A. U., Periñán, M. T., Okubadejo, N. U., Klein, C., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.07.014 · Cited by 11
Increased Free Water in the Putamen in Idiopathic REM Sleep Behavior Disorder
Zhang, D., Zhou, L., Yao, J., Shi, Y., He, H., Wei, H., Tong, Q., Liu, J., & Wu, T. (2023) · Movement Disorders · doi:10.1002/mds.29499 · Cited by 9
Loss of MINAR2 impairs motor function and causes Parkinson’s disease-like symptoms in mice
Ho, R. X.-Y., Amraei, R., Cena, K. O. C. D. L., Sutherland, E. G., Mortazavi, F., Stein, T. D., Chitalia, V. C., & Rahimi, N. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa047 · Cited by 9
Oh, Y., Choi, J. H., & Kwon, D. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-160874 · Cited by 9
Frontotemporal Lobe Degeneration as Origin of Scans Without Evidence of Dopaminergic Deficit
Menéndez‐González, M., Álvarez-Avellón, T., Salas-Pacheco, J. M., Alonso, B. D. C., Wyman‐Chick, K. A., & Arias-Carrión, Ó. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00335 · Cited by 9
Li, J., Grimes, K. F., Saade, J., Tomlinson, J. J., Mestre, T., Schade, S., Weber, S., Dakna, M., Wicke, T., Lang, E., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00904-5 · Cited by 8
Predicting progression in patients with Parkinson's disease
Blauwendraat, C., Bandrés‐Ciga, S., & Singleton, A. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30331-9 · Cited by 8
Kwon, D.-Y., Kwon, Y.-R., Ko, J., & Kim, J.-W. (2023) · Technology and Health Care · doi:10.3233/thc-236045 · Cited by 8
Chan, Y. E., Chen, M., Bai, Y., Li, C., Chen, T., & Su, T. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.056 · Cited by 8
Poortvliet, P. C., O’Maley, K. A., Silburn, P. A., & Mellick, G. D. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00686 · Cited by 7
Skogar, Ö., Nilsson, M., & Lökk, J. (2022) · Brain Circulation · doi:10.4103/bc.bc_33_22 · Cited by 7
Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging
Massa, J., & Chahine, L. M. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-181517 · Cited by 7
Saffie-Awad, P., Grant, S., Makarious, M., Elsayed, I., Sanyaolu, A. O., Crea, P. W., Schuh, A. S. S., Levine, K., Vitale, D., Koretsky, M. J., et al. (2025) · npj Parkinson's Disease · doi:10.1038/s41531-025-00967-4 · Cited by 8
Liu, W., Xu, L., Wang, X., & Wang, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0329980 · Cited by 6
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects
Pellecchia, M. T., Picillo, M., Moccia, M., Spina, E., & Barone, P. (2016) · Journal of Parkinsonism and Restless Legs Syndrome · doi:10.2147/jprls.s85488 · Cited by 7
Jin, H., Chen, J., Li, K., Zhang, J., Gu, C.-C., Mao, C., Yang, Y., Wang, F., & Liu, C. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.03.017 · Cited by 6
Hou, W., Kuo, K. N., Chen, M.-J., Chang, Y.-M., Tsai, H.-W., Chan, D., Su, C., Han, D., Shen, H.-N., & Li, C. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045411 · Cited by 6
A screening tool to detect clinical manganese neurotoxicity
Racette, B. A., Gross, A., Criswell, S. R., Checkoway, H., & Nielsen, S. S. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.02.009 · Cited by 6
Raihan, S. M. S., Zisad, S. N., Islam, R. U., Hossain, M. S., & Andersson, K. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-86993-9_35 · Cited by 6
Dementia Research—A Roadmap for the Next Decade
Traynor, B. J., & Rademakers, R. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.5004 · Cited by 6
Environmental and genetic risk factors for Parkinson's disease
Belbasis, L., Bellou, V., & Evangelou, E. (2020) · Diagnosis and Management in Parkinson's Disease · doi:10.1016/b978-0-12-815946-0.00004-1 · Cited by 1
Awad, P. S., Makarious, M. B., Elsayed, I., Sanyaolu, A. O., Crea, P. W., Schuh, A. F. S., Levine, K. S., Vitale, D., Koretsky, M. J., Kim, J., et al. (2023) · medRxiv · doi:10.1101/2023.11.28.23299090 · Cited by 5
Wang, Q.-L., Gu, X., Yang, L., Jiang, Y., Zhang, J., & He, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1417515 · Cited by 4
Li, J., Mestre, T., Mollenhauer, B., Frasier, M. A., Tomlinson, J. J., Trenkwalder, C., Ramsay, T., Manuel, D. G., & Schlossmacher, M. G. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00360-5 · Cited by 4
The Role of Nurses in Parkinson's Disease
Tosin, M. H. D. S., & de Oliveira, B. G. R. B. (2016) · InTech eBooks · doi:10.5772/63162 · Cited by 4
A diagnostic algorithm for Parkinson's disease: what next?
Goldman, S. M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00192-1 · Cited by 3
Novel Variants Linked to the Prodromal Stage of Parkinson’s Disease (PD) Patients
Badawy, M. T., Salama, A. A., & Salama, M. (2024) · Diagnostics · doi:10.3390/diagnostics14090929 · Cited by 2
Islam, M. M., Templeton, J. M., Poellabauer, C., & Mondal, A. M. (2024) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm62325.2024.10822140 · Cited by 2
Wang, J., Zou, Y., Zhang, S., Yuan, L., Tang, H., She, W., Li, R., Wei, S., Tao, J., Chen, H., et al. (2026) · Critical Public Health · doi:10.1080/09581596.2025.2605788 · Cited by 2
Diagnosing Parkinson’s Disease Using Voice Features Based On Deep Learning And Information Gain
Ramya, N., & Suganya, S. (2023) · International Conference on Energy, Materials and Communication Engineering (ICEMCE) · doi:10.1109/icemce57940.2023.10434058 · Cited by 2
Compositional Features and Codon Usage Pattern of Genes Associated with Parkinson’s Disease
Uddin, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04091-x · Cited by 2
Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s DiseasePreprint
Tsukita, K., Sakamaki‐Tsukita, H., Kaiser, S., Zhang, L., Messa, M., Serrano‐Fernández, P., & Takahashi, R. (2022) · medRxiv · doi:10.1101/2022.06.08.22276035 · Cited by 2
Polygenic risk score-based prediction for Parkinson’s diseasePreprint
Wen, Y., Zhang, J., Yu, H., & Liu, L. (2023) · Research Square · doi:10.21203/rs.3.rs-3432605/v1 · Cited by 2
Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
Nabizadeh, F., KamaliZonouzi, S., & Noori, M. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.10.001 · Cited by 1
Liu, J., Li, Y.-Z., Yang, H. J., Duan, C., & Li, T. (2026) · NeuroImage · doi:10.1016/j.neuroimage.2026.121892 · Cited by 1
Islam, M. M., Templeton, J. M., Sobhan, M., Poellabauer, C., & Mondal, A. M. (2026) · Communications in computer and information science · doi:10.1007/978-3-032-26028-4_20 · Cited by 1
Xiao, C., He, D., Xin, B., & Wang, X. (2018) · International Conference on Control, Automation, Robotics and Vision (ICARCV) · doi:10.1109/icarcv.2018.8581191 · Cited by 1
Genetic-based diagnostics of Parkinson’s disease and other Parkinsonian syndromes
Somerville, E. N., & Gan‐Or, Z. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2427625 · Cited by 1
Mittal, U., Singla, N., & Gupta, G. (2020) · Wiley eBooks · doi:10.1002/9781119711582.ch17 · Cited by 1
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study
Erro, R., & Barone, P. (2015) · Movement Disorders · doi:10.1002/mds.26440
Gene Linkage and Systems Biology
Cookson, M. R. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_19
Flipping the odds of drug development success through human genomicsPreprint
Hingorani, A. D., Kuan, V., Finan, C., Krüger, F. A., Gaulton, A., Chopade, S., Sofat, R., MacAllister, R. J., Overington, J. P., Hemingway, H., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/170142
Lucas‐Jiménez, O., Diez, I. P., Ojeda, N., Ibarretxe‐Bilbao, N., Peña, J., Tijero, B., Galdós, M., Murueta‐Goyena, A., Pino, R. D., Acera, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/551507
Basi molecolari della malattia di Parkinson
Monin, M., Lesage, S., & Brice, A. (2019) · EMC - Neurologia · doi:10.1016/s1634-7072(18)41584-x
Analytical study of Parkinson's diagnosis through classification techniques
Karthikayani, K., & Nandakumar, R. (2020) · AIP conference proceedings · doi:10.1063/5.0028563
Evaluation of the PREDIGT Score in Discriminating Parkinson Disease From Neurological HealthPreprint
Li, J., Mestre, T., Mollenhauer, B., Frasier, M. A., Tomlinson, J. J., Trenkwalder, C., Ramsay, T., Manuel, D. G., & Schlossmacher, M. G. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3737455
Parkinson's disease: Genetic-driven therapeutic approaches
Sardi, S. P., & Baptista, M. A. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00008-2
Chen, G., Zeng, L., Liu, Y., Yu, Y., Sun, P., & Yao, T. (2021) · Scientific Programming · doi:10.1155/2021/8210526
Renton, A. E., & Goate, A. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0051
Encoding and decoding multimodal brain images for disease biomarker discovery
Chan, Y. H. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/173338
Language Modeling Screens Parkinson’s Disease with Self-reported QuestionnairesPreprint
Reyes, D. M., Hahn, J., Shen, L., & Yan, P. (2024) · medRxiv · doi:10.1101/2024.09.23.24314200
Hassanin, E., Landoulsi, Z., Pachchek, S., Krawitz, P. M., Maj, C., Krüger, R., May, P., & Bobbili, D. R. (2025) · medRxiv · doi:10.1101/2025.01.23.25320896
Arrington, L., van Dijkman, S. C., Plan, E. L., & Karlsson, M. O. (2025) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70000
Heineman, A., Linck, J. H., Eylon, A., & Parmar, M. S. (2025) · Cureus · doi:10.7759/cureus.91510
Minster, N., & Jafri, M. S. (2025) · medRxiv · doi:10.1101/2025.09.02.25334526
Step, K., Sima, C. A. A. N., Grant, S. M., Kim, J. J., Waldo, E., Bardien, S., & Mata, I. F. (2025) · medRxiv · doi:10.1101/2025.09.29.25336747
Veningston, K., Selvan, C., Rao, P. V. V., Ronalda, M., Charan, K., Sekhar, S. C., & Chowdary, M. A. (2025) · International Conference on Artificial Intelligence for Computing, Astronomy and Renewable Energy (AICARE) · doi:10.1109/aicare66005.2025.11402688
Step, K., Sima, C. A. N. N., Grant, S., Kim, J., Waldo, E., Bardien, S., & Mata, I. (2026) · PLoS Genetics · doi:10.1371/journal.pgen.1012064
Kwon, D. Y., Ko, J., Kwon, Y., & Kim, J.-W. (2026) · Parkinson s Disease · doi:10.1155/padi/6400390
Adaptive time-frequency decomposition informer for pathological rest tremor sequence prediction
Xiao, F., Gao, R., Huang, C., Mu, J., & Wang, Y. (2026) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2026.103428
Metadata
- Authors
- Nalls, M. A., McLean, C. Y., Rick, J., Eberly, S., Hutten, S. J., Gwinn, K., Sutherland, M., Martinez, M., Heutink, P., Williams, N. M., Hardy, J., Gasser, T., Brice, A., Price, T. R., Nicolas, A., Keller, M. F., Molony, C., Gibbs, J. R., Chen-Plotkin, A., Suh, E., Letson, C., Fiandaca, M. S., Mapstone, M., Federoff, H. J., Noyce, A. J., Morris, H., Van Deerlin, V. M., Weintraub, D., Zabetian, C., Hernandez, D. G., Lesage, S., Mullins, M., Conley, E. D., Northover, C. A. M., Frasier, M., Marek, K., Day-Williams, A. G., Stone, D. J., Ioannidis, J. P. A., & Singleton, A. B.
- Affiliations
- National Institutes of Health (US)
- 23andMe (United States) (US)
- University of Pennsylvania (US)
- University of Rochester Medicine (US)
- Michael J. Fox Foundation (US)
- Université Toulouse III - Paul Sabatier (FR)
- German Center for Neurodegenerative Diseases (DE)
- Cardiff University (GB)
- UCL Queen Square Institute of Neurology (GB)
- Hertie Institute for Clinical Brain Research (DE)
- Centre National de la Recherche Scientifique (FR)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Georgetown University Medical Center (US)
- VA Puget Sound Health Care System (US)
- Biogen (United States) (US)
- Stanford Medicine (US)
- Corresponding author
- Singleton, Andrew B
- ORCID
- Nalls, Mike A
- McLean, Cory Y
- Eberly, Shirley
- Hutten, Samantha J
- Gwinn, Katrina
- Sutherland, Margaret
- Martinez, Maria
- Heutink, Peter
- Williams, Nigel M
- Hardy, John
- Gasser, Thomas
- Brice, Alexis
- Nicolas, Aude
- Keller, Margaux F
- Molony, Cliona
- Gibbs, J Raphael
- Suh, Eunran
- Fiandaca, Massimo S
- Mapstone, Mark
- Federoff, Howard J
- Noyce, Alastair J
- Morris, Huw
- Weintraub, Daniel
- Zabetian, Cyrus
- Hernandez, Dena G
- Lesage, Suzanne
- Frasier, Mark
- Ioannidis, John P A
- Singleton, Andrew B
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 14
- Issue
- 10
- Pages
- 1002-1009
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC4575273
- OpenAlex
- W2098399146
- Cited by
- 204
- References
- 21
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 15 · 2023: 10 · 2022: 16 · 2021: 15 · 2020: 29 · 2019: 21 · 2018: 21 · 2017: 28 · 2016: 19 · 2015: 5
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- DZNE Pub (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Funders
- NINDS (U01NS082134, U01NS082157, U01NS082151, U01NS082137, U01NS082148, U01NS082133, grant P50NS053488 and P50 NS062684)
- Parkinson's UK (Grants 8047)
- Medical Research Council UK (G0700943, G1100643)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, non-invasive diagnosis, olfactory function, genetic risk, family history (medicine), imaging biomarkers, dopaminergic deficit, Parkinson's Progression Markers Initiative, external validation, early detection, disease prediction, clinical classification, Parkinson's disease biomarker
- MeSH terms
- Aged, Female, Humans, Male, Middle Aged, Parkinson Disease, Models, Statistical, Cohort Studies, Disease Progression, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
